Fiscella K. 2005. Race, genes, and preterm delivery. Journal of the National Medical Association 97(11):1516-1526.

Fiscella KMM, Franks PM, Kendrick JSM, Meldrum SM, Kieke BA Jr. 2002. Risk of preterm birth that is associated with vaginal douching. American Journal of Obstetrics and Gynecology 186(6):1345-1350.

Fitzgerald JF, Levin SC, Naulty JS, Collins JG. 1999. Evaluation of intrathecal phenol injection using a rat model: Scientific abstracts. Regional Anesthesia and Pain Medicine 24(3 Suppl 1):40.

Fledelius HC, Greisen G. 1993. Very pre-term birth and visual impairment: A retrospective investigation of 411 infants of gestational age 30 weeks or less, 1983-89 Rigshospitalet, Copenhagen. Acta Ophthalmologica Supplement 210:63-65.

Flegal KM, Harlan WR, Landis JR. 1988. Secular trends in body mass index and skinfold thickness with socioeconomic factors in young adult women. American Journal of Clinical Nutrition 48(3):535-543.

Fletcher JM, Francis DJ, Thompson NM, Brookshire BL, Bohan TP, Landry SH, Davidson KC, Miner ME. 1992. Verbal and nonverbal skill discrepancies in hydrocephalic children. Journal of Clinical and Experimental Neuropsychology 14(4):593-609.

Floyd RC, McLauglin BN, Perry KG Jr., Martin RW, Sullivan CA, Morrison JC. 1995. Magnesium sulfate or nifedipine hydrochloride for acute tocolysis of preterm labor: Efficacy and side effects. Journal of Maternal-Fetal Investigation 5(1):25-29.

Flynn JR. 1999. Searching for justice: The discovery of IQ gains over time. American Psychologist 54(1):5-20.

Follett PL, Koh S, Fu JM, Volpe JJ, Jensen FE. 2000. Protective effects of topiramate in a rodent model of periventricular leukomalacia. Annals of Neurology 48:34A.

Ford GW, Doyle LW, Davis NM, Callanan C. 2000. Very low birth weight and growth into adolescence. Archives of Pediatrics and Adolescent Medicine 154(8):778-784.

Fortier I, Marcoux S, Brisson J. 1995. Maternal work during pregnancy and the risks of delivering a small-for-gestational-age or preterm infant. Scandinavian Journal of Work, Environment, and Health 21(6):412-418.

Fortunato SJ, Menon R, Lombardi SJ. 1999. MMP/TIMP imbalance in the amniotic fluid during PROM: An indirect support for endogenous pathway to membrane rupture. Journal of Perinatal Medicine 27:362-368.

Fortunato SJ, Menon R, Bryant C, Lombardi SJ. 2000a. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. American Journal of Obstetrics and Gynecology 182:1468-1476.

Fortunato, SJ, Menon, R, Lombardi, SJ. 2000b. Amniochorion gelatinase-gelatinase inhibitor imbalance in virto: A possible infectious pathway to rupture. Obstetrics and Gynecology 95:240-244.

Fossett JW, Perloff JD, Kletke PR, Peterson JA. 1992. Medicaid and access to child health care in Chicago. Journal of Health Politics, Policy, and Law 17(2):273-298.

Fowlie PW. 2005. Managing the baby with a patent ductus arteriosus. More questions than answers? Archives of Disease in Childhood: Fetal and Neonatal Edition 90(3):F190.

Fowlie PW, Davis PG. 2002. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews (Online: Update Software) 3.

Fox MD, Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. 1993. Neonatal morbidity between 34 and 37 weeks’ gestation. Journal of Perinatology: Official Journal of the California Perinatal Association 13(5):349-353.

Front Matter (R1-R18)

Summary (1-30)

1 Introduction (31-52)

SECTION I Measurement : 2 Measurement of Fetal and Infant Maturity (53-83)

Section I Recommendations (84-86)

SECTION II Causes of Preterm Birth: 3 Behavioral and Psychosocial Contributors to Preterm Birth (87-123)

4 Sociodemographic and Community Factors Contributing to Preterm Birth (124-147)

5 Medical and Pregnancy Conditions Associated with Preterm Birth (148-168)

6 Biological Pathways Leading to Preterm Birth (169-206)

7 Role of Gene-Environment Interactions in Preterm Birth (207-228)

8 Role of Environmental Toxicants in Preterm Birth (229-254)

Section II Recommendations (255-258)

SECTION III Diagnosis and Treatment of Preterm Labor: 9 Diagnosis and Treatment of Conditions Leading to Spontaneous Preterm Birth (259-307)

Section III Recommendations (308-310)

SECTION IV Consequences of Preterm Birth: 10 Mortality and Acute Complications in Preterm Infants (311-345)

11 Neurodevelopmental, Health, and Family Outcomes for Infants Born Preterm (346-397)

12 Societal Costs of Preterm Birth (398-429)

Section IV Recommendations (430-432)

SECTION V Research and Policy: 13 Barriers to Clinical Research on Preterm Birth and Outcomes of Preterm Infants (433-454)

14 Public Policies Affected by Preterm Birth (455-472)

Section V Recommendations (473-476)

15 A Research Agenda to Investigate Preterm Birth (477-492)

References (493-590)

Appendix A Data Sources and Methods (591-603)

Appendix B Prematurity at Birth: Determinents, Consequences, and Geographic Variation (604-643)

Appendix C A Review of Ethical Issues involved in Premature Birth (644-687)

Appendix D A Systematic Review of Costs Associated with Preterm Birth (688-724)

Appendix E Selected Programs Funding Preterm Birth Research (725-731)

Appendix F Committee and Staff Biographies (732-740)

Index (741-772)